Kiromic Biopharma Inc (KRBP)

Kiromic Biopharma Inc (KRBP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $214,931; returns 1 day +0.1%, 1 week +1.1%, 1 year +2.8%.

Kiromic BioPharma, Inc. (KRBP) is a clinical-stage biotherapeutics company specializing in the development of allogeneic, off-the-shelf cell therapies for solid tumors. The company leverages its proprietary DIAMOND® AI 2.0 platform for target discovery and its manufacturing facility to produce Gamma Delta T-cell (GDT) therapies.

Groups KRBP belongs to

• Clinical Stage Biotech
• Biotechnology
• Biopharmaceutical
• Oncology
• Cancer Therapeutics
• Clinical Stage
• Life Sciences
• AI in Healthcare
• Artificial Intelligence
• R&D

KRBP financial model: income statement, cash flow and balance sheet